Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Keating

Showing results (71-80 of 341) with videos related to

Pageof 35
Sort By:
Leukemia & Lymphoma|October 4, 2017
Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cellsHima V Vangapandu, Huiqin Chen, William G Wierda, et al.
Blood|April 10, 2004
Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sézary syndromeDaniel J Lenihan, Alvaro J Alencar, Deborah Yang, et al.
Leukemia & Lymphoma|December 25, 2003
Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual diseaseApostolia M Tsimberidou, Francis J Giles, Hagop M Kantarjian, et al.
Blood|February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cellsClaudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.
Blood|March 27, 2004
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categoriesMarco Herling, Joseph D Khoury, LaBaron T Washington, et al.
Blood|November 23, 2006
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cellsRamadevi Nimmanapalli, Mi-Ae Lyu, Min Du, et al.
Haematologica|December 30, 2006
Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia--case report and review of the literatureBilal Ahmed, Elihu Estey, John Manning, et al.
Blood|July 27, 2007
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemiaAndrea Bürkle, Matthias Niedermeier, Annette Schmitt-Gräff, et al.
Pageof 35

Showing results (71-80 of 341) with videos related to

Sort By:
Pageof 35
Leukemia & Lymphoma|October 4, 2017
Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cellsHima V Vangapandu, Huiqin Chen, William G Wierda, et al.
Blood|April 10, 2004
Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sézary syndromeDaniel J Lenihan, Alvaro J Alencar, Deborah Yang, et al.
Leukemia & Lymphoma|December 25, 2003
Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual diseaseApostolia M Tsimberidou, Francis J Giles, Hagop M Kantarjian, et al.
Blood|February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cellsClaudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.
Blood|March 27, 2004
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categoriesMarco Herling, Joseph D Khoury, LaBaron T Washington, et al.
Blood|November 23, 2006
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cellsRamadevi Nimmanapalli, Mi-Ae Lyu, Min Du, et al.
Haematologica|December 30, 2006
Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia--case report and review of the literatureBilal Ahmed, Elihu Estey, John Manning, et al.
Blood|July 27, 2007
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemiaAndrea Bürkle, Matthias Niedermeier, Annette Schmitt-Gräff, et al.
Pageof 35